NPI: 1376848473 · JACKSONVILLE, AR 72076 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/20/2011
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 01/20/2011 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,301 | $32K |
| 2019 | 6,191 | $47K |
| 2020 | 1,030 | $11K |
| 2021 | 159 | $4K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 6,078 | 332 | $65K |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 3,272 | 291 | $15K |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,856 | 175 | $5K |
| 83970 | 39 | 37 | $4K | |
| 82728 | 28 | 24 | $2K | |
| A4657 | Syringe, with or without needle, each | 146 | 137 | $1K |
| 85041 | 65 | 61 | $422.79 | |
| 85048 | 65 | 61 | $357.09 | |
| 83550 | 16 | 12 | $277.89 | |
| 83540 | 16 | 12 | $244.65 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 17 | 12 | $29.04 |
| J1756 | Injection, iron sucrose, 1 mg | 83 | 24 | $0.00 |